{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/candida-oral/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"543a3d8a-2699-5ab1-8d60-91f808bddfdf","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field b9bca824-6fad-4b79-afc3-e0a2ead232ed --><h2>How common is it?</h2><!-- end field b9bca824-6fad-4b79-afc3-e0a2ead232ed -->","summary":"","htmlStringContent":"<!-- begin item 3b384b25-cb14-40f4-9f52-7c5a714d9f56 --><!-- begin field ba7a025e-f930-4a7b-bf5e-6341d67b56dd --><ul><li><strong><em>Candida </em>is part of the normal commensal flora in the human digestive tract.</strong> The oral carriage is reported to be [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Patil, 2015</a>]:<ul><li>30–45% in healthy adults.</li><li>45% in neonates.</li><li>45–65% in healthy children.</li></ul></li><li><strong>Oral candidiasis is the most common human opportunistic fungal infection of the oral cavity </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Coronado-Castellote, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Garcia-Cuesta, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">BMJ, 2017</a>]<strong>.</strong> However, it is rare in healthy adults and older children, and tends to mostly affect [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Hoppe, 1997a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Samaranayake et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Hay and Ashbee, 2010</a>]:<ul><li><strong>Young children and infants </strong>(due to immature immunity) — it affects about 5% of newborns, increasing to 14% in the fourth week of life before decreasing gradually thereafter.</li><li><strong>Older, debilitated people </strong>(due to weakened immunity) — up to 10% of debilitated, older people are affected.</li><li><strong>People with compromised or suppressed immune systems:</strong><ul><li>Oropharyngeal candidiasis affects between 15–60% of people with haematological or oncological cancer during periods of immunosuppression [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Pankhurst, 2013</a>].</li><li>About 50% of people receiving chemotherapy (for the treatment of cancer) and 70% of people receiving radiation treatment experience oral candidiasis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">BMJ, 2017</a>].</li><li>Oral candidiasis occurs in about 90% of people with AIDS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Pankhurst, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">BMJ, 2017</a>]. A literature analysis found that in children with HIV/AIDS, the prevalence of oral candidiasis varied from 2.9% in American HIV-positive children undergoing highly active antiretroviral therapy to 88% in Chilean HIV-positive children without antiretroviral therapy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Gait&aacute;n-Cepeda, 2015</a>].</li></ul></li><li><strong>People with additional <a class=\"topic-reference internal-reference\" href=\"/topics/candida-oral/background-information/causes-risk-factors/\">risk factors</a>, </strong>including:<ul><li><strong>Diabetes mellitus </strong>— studies on the prevalence of oral mucosal disorders in people with diabetes showed higher prevalence of oral mucosal disorders (including <a class=\"topic-reference internal-reference\" href=\"/topics/candida-oral/diagnosis/diagnosis/\">median rhomboid glossitis</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/candida-oral/diagnosis/diagnosis/\">denture stomatitis</a>) in people with diabetes compared with people without: 45% in people with type 1 diabetes compared with 25% in people without, and 45–88% in people with type 2 diabetes compared with 38–45% in people without [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Gonz&aacute;lez-Serrano, 2016</a>].</li><li><strong>Dental prostheses </strong>— about 50–70% of denture wearers are predisposed to oral candidal infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Pankhurst, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Singh, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Patil, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Martonffy, 2015</a>].</li><li><strong>Smoking </strong>— a prospective cross-sectional clinical study done to ascertain the prevalence and degree of carriage of <em>Candida</em> in the oral cavities of a non-cancer population found that smokers are nearly seven times more likely to have oral candidiasis that non-smokers, and people with high candidal colonization are more likely to be current smokers [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-oral/references/\">Mun, 2016</a>]. </li></ul></li></ul></li></ul><!-- end field ba7a025e-f930-4a7b-bf5e-6341d67b56dd --><!-- end item 3b384b25-cb14-40f4-9f52-7c5a714d9f56 -->","topic":{"id":"0f1d88eb-55a0-530e-a259-eb14f0dda14a","topicId":"b0c376a4-6364-437c-b2b0-0b37c1f9457c","topicName":"Candida - oral","slug":"candida-oral","lastRevised":"Last revised in September 2019","chapters":[{"id":"18d6ae12-7e70-5db1-bc04-693d5cb239d6","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"5e30b9ac-9bad-5d72-95a0-522910be9b02","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a6e1a973-1e09-50e9-884c-3320ada5f64a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"e89a359d-f797-5ff2-a94a-511199763a4b","slug":"changes","fullItemName":"Changes"},{"id":"e3aa3dcf-265b-5bf3-8920-86af41a82b81","slug":"update","fullItemName":"Update"}]},{"id":"1c10a9c3-b22e-5e15-9f5e-fd1b321eda87","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2044b7f8-9a22-580a-a6ee-d09f8e57e822","slug":"goals","fullItemName":"Goals"},{"id":"a2a6fc92-6ee5-5340-8de6-99645565cff9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"3d375136-1f32-5b18-bfaa-072565762749","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5055e999-d687-5080-a905-6d314ff96a68","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7974345e-7b16-5e65-be63-f0b8a60779ef","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"19434a87-22cd-57f9-9507-fa3784bc88e9","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"52cafe43-224c-5c66-934b-d40eb1b71de5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"372003e6-a514-5b66-8e01-c0c4c24fcf84","slug":"definition","fullItemName":"Definition"},{"id":"6209fe71-2228-5859-966c-9dbcca7da121","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"543a3d8a-2699-5ab1-8d60-91f808bddfdf","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f317e3a4-4b69-5c95-9d13-c551a893ac44","slug":"complications","fullItemName":"Complications"},{"id":"a19dd915-bb50-52c5-94e7-3c7f215a0ac3","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"8b32d0b5-0a06-58dc-9e26-cd5930c9b82e","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"e6f234d8-47d7-5740-8739-58962c6c3a1c","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"f276724c-839b-5e50-9ed1-f685c12b1c5a","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"32ef3be0-0861-5c08-932e-c4295def32b8","fullItemName":"Management","slug":"management","subChapters":[{"id":"4dbdf8e9-97b5-54f2-8023-94e3da894f99","slug":"children-not-immunocompromised","fullItemName":"Scenario: Children (not immunocompromised)"},{"id":"462896e2-aa8a-5693-80bc-cb11b1d29ef2","slug":"adults-young-people-not-immunocompromised","fullItemName":"Scenario: Adults and young people (not immunocompromised)"},{"id":"10d79010-5f47-51a1-be04-e6086178a3da","slug":"adults-immunosuppressive-treatment","fullItemName":"Scenario: Adults (immunosuppressive treatment)"},{"id":"13250ef8-0c39-5e07-b367-3b38fab47e57","slug":"adults-hiv-positive","fullItemName":"Scenario: Adults (HIV positive)"}]},{"id":"800e543f-aa34-535b-982f-b67228787534","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"50f16582-74d2-54ab-82c2-4d34b643efbd","slug":"miconazole-oral-gel","fullItemName":"Miconazole oral gel"},{"id":"52caf1d3-9e52-581c-aa51-d6c5e0d34239","slug":"nystatin-suspension","fullItemName":"Nystatin suspension"},{"id":"eaecb9ab-d5ac-5b61-b987-ed97a3b933fd","slug":"fluconazole-oral","fullItemName":"Fluconazole - oral"}]},{"id":"9d6aa898-2416-5c14-92f0-effd8eee476e","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"aefe3a29-b255-5d42-81cf-2ec2c53a1d28","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"f1d318f6-b308-52db-a6ef-c314467ec43f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4b0b04f2-6c79-5699-8121-895467604792","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"545d5c41-fb5a-5561-9a76-8cf64fe0b179","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"098d8b0b-527b-57aa-b706-e69ada6b04fd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6e055ac7-10af-5a82-b3ff-1d1c789b3c91","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4e3093df-a561-5cba-84a5-99f5890a58a5","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"52cafe43-224c-5c66-934b-d40eb1b71de5","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}